Zhihong Li

10.7k total citations · 2 hit papers
428 papers, 6.9k citations indexed

About

Zhihong Li is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Zhihong Li has authored 428 papers receiving a total of 6.9k indexed citations (citations by other indexed papers that have themselves been cited), including 155 papers in Molecular Biology, 71 papers in Cancer Research and 48 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Zhihong Li's work include Cancer-related molecular mechanisms research (41 papers), RNA modifications and cancer (33 papers) and Sarcoma Diagnosis and Treatment (29 papers). Zhihong Li is often cited by papers focused on Cancer-related molecular mechanisms research (41 papers), RNA modifications and cancer (33 papers) and Sarcoma Diagnosis and Treatment (29 papers). Zhihong Li collaborates with scholars based in China, United States and Australia. Zhihong Li's co-authors include Chao Tu, Tang Liu, Wanchun Wang, Lin Qi, Zhengjun Lin, Yanlin Wu, Guoqing Li, Zhongyue Liu, Jieyu He and Wenchao Zhang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Chemical Society Reviews and Nucleic Acids Research.

In The Last Decade

Zhihong Li

404 papers receiving 6.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Epigenetic regulation in metabolic diseases: mechanisms and advances in clinical study

2023 222 citations Zhengjun Lin, Zhihong Li et al. profile →
Mesenchymal stem cell-derived exosomes in cancer therapy resistance: recent advances and therapeutic potential

2022 197 citations Zhengjun Lin, Guoqing Li et al. Molecular Cancer profile →

Peers

Countries citing papers authored by Zhihong Li

Since Specialization

Citations

This map shows the geographic impact of Zhihong Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhihong Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhihong Li more than expected).

Fields of papers citing papers by Zhihong Li

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhihong Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhihong Li. The network helps show where Zhihong Li may publish in the future.

Co-authorship network of co-authors of Zhihong Li

This figure shows the co-authorship network connecting the top 25 collaborators of Zhihong Li. A scholar is included among the top collaborators of Zhihong Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhihong Li. Zhihong Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Deciphering the role of liquid-liquid phase separation in sarcoma: Implications for pathogenesis and treatment 2025 ·Cancer Letters ·(unknown), Hua Wang, (unknown), Bin Ren, (unknown), Zhihong Li, Chao Tu	7
2	A fibroblast‐specific miRNA functional cluster in remote exosomes aggravates myocardial ischaemia/reperfusion injury via the Rap1b/ERK1/2 axis 2025 ·British Journal of Pharmacology ·Rui Zhang, (unknown), Jiarui Jin, Xuemei Fu, Hailin Zhu, Xiaoxia Huang, Mingyuan He, Zhihong Li, (unknown), Hairuo Lin, Tong Zhang, Wangjun Liao, (unknown), Qiancheng Wang, (unknown), Yulin Liao	0
3	Mechanism Research of QingReJieDu Formula for Treating Hepatitis B Virus Based on Network Pharmacology 2024 ·Phytomedicine ·Caixia Jia, Hong‐Xing Wu, Aiqing Yang, Aiping Chen, Xueting Wang, (unknown), (unknown), Gangqiao Zhou, Zhihong Li, Jianxin Chen	2
4	Cancer therapy resistance mediated by cancer-associated fibroblast-derived extracellular vesicles: biological mechanisms to clinical significance and implications 2024 ·Molecular Cancer ·Zhengjun Lin, Guoqing Li, Ke Jiang, Zhihong Li, Tang Liu	25
5	Maternal NO ₂ exposure and fetal growth restriction: Hypoxia transmission and lncRNAs-proinflammation-mediated abnormal hematopoiesis 2024 ·Proceedings of the National Academy of Sciences ·(unknown), Huifeng Yue, (unknown), (unknown), Dan Li, Li Ma, (unknown), Jing He, Zhihong Li, Guangke Li, Wei Yan, Nan Sang	2
6	Heat Shock Protein Genes Affect the Rapid Cold Hardening Ability of Two Invasive Tephritids 2024 ·Insects ·Yuning Wang, Yan Zhao, Junzheng Zhang, Zhihong Li	2
7	ATP-elicited Cation Fluxes Promote Volume-regulated Anion Channel LRRC8/VRAC Transport cGAMP for Antitumor Immunity 2024 ·The Journal of Immunology ·(unknown), Limin Cao, Zhihong Li, (unknown), Xia Chen, (unknown), Xiaoxiao He, Junke Zheng, Liu L, Xin‐Ming Jia, Hui Xiao	7
8	Mitigation of Cisplatin-Induced Nephrotoxicity and Augmentation of Anticancer Potency via Tea Polyphenol Nanoparticles’ Codelivery of siRNA from CRISPR/Cas9 Screened Targets 2024 ·ACS Applied Materials & Interfaces ·(unknown), Chengyao Feng, Wenchao Zhang, Lin Qi, Binfeng Liu, Hua Wang, Chenbei Li, Zhihong Li, Chao Tu, Wenhu Zhou	5
9	Titration of Sedentary Behavior With Varying Physical Activity Levels Reduces Mortality in Patients With Type 2 Diabetes 2024 ·The Journal of Clinical Endocrinology & Metabolism ·(unknown), (unknown), Zhihong Li, Xiaoxia Huang, (unknown), (unknown), Wangjun Liao, (unknown), Jinghua Li, Hairuo Lin, (unknown), Yulin Liao	3
10	SPP1 could be an immunological and prognostic biomarker: From pan‐cancer comprehensive analysis to osteosarcoma validation 2024 ·The FASEB Journal ·Zhiming Zhang, Binfeng Liu, Zhengjun Lin, (unknown), (unknown), Zhihong Li	5
11	Draft genome of Castanopsis chinensis, a dominant species safeguarding biodiversity in subtropical broadleaved evergreen forests 2023 ·BMC Genomic Data ·Pan Chen, Juyu Lian, Bin Wu, Honglin Cao, Zhihong Li, Zheng‐Feng Wang	2
12	Identification of candidate genes and chemicals associated with osteoarthritis by transcriptome-wide association study and chemical-gene interaction analysis 2023 ·Arthritis Research & Therapy ·Lin Mei, Zhiming Zhang, Ruiqi Chen, Zhongyue Liu, Xiaolei Ren, Zhihong Li	7
13	Integrative analysis of TROAP with molecular features, carcinogenesis, and related immune and pharmacogenomic characteristics in soft tissue sarcoma 2023 ·SHILAP Revista de lepidopterología ·Chao Tu, Binfeng Liu, Chenbei Li, Chengyao Feng, Hua Wang, Haixia Zhang, Shasha He, Zhihong Li	4
14	A Novel Glutamine Metabolism-Related Gene Signature in Prognostic Prediction of Osteosarcoma 2022 ·SHILAP Revista de lepidopterología ·Lu Wan, Wenchao Zhang, Zhongyue Liu, (unknown), Chao Tu, Zhihong Li	4
15	A retro-inverso modified peptide alleviated ovalbumin-induced asthma model by affecting glycerophospholipid and purine metabolism of immune cells 2022 ·Pulmonary Pharmacology & Therapeutics ·Shumei Ma, (unknown), Zhihong Li, Liang Li, Yue Feng, Xiaowei Wang, Jiahui Wang, Zhengdan Zhu, Zhiyong Wang, Juan Wang, Yi Zhun Zhu, Li Liu	5
16	[A retrospective analysis on the diagnosis and reporting of imported malaria in Jiangxi Province during 2012-2015]. 2017 ·PubMed ·Lei Lei, Zhigui Xia, Zhihong Li, Yanfeng Gong, Ning Xiao	1
17	[Risk assessment of secondary transmission induced by imported malaria in Jiangxi Province]. 2017 ·PubMed ·Lei Lei, Zhigui Xia, Zhihong Li, Shang Xia, Yanfeng Gong, Ning Xiao	2
18	AMG 925 Is a Dual FLT3/CDK4 Inhibitor with the Potential to Overcome FLT3 Inhibitor Resistance in Acute Myeloid Leukemia 2014 ·Molecular Cancer Therapeutics ·Cong Li, Liqin Liu, Lingming Liang, Zhen Xia, Zhihong Li, Xianghong Wang, Lawrence R. McGee, (unknown), Angus M. Sinclair, Alexander Kamb, Dineli Wickramasinghe, Kang Dai	27
19	ADVANCES ON THE POTENTIAL GSSP FOR THE BASE OF MIDDLE ORDOVICIAN SERIES——HUANGHUACHANG SECTION 2005 ·Dicengxue zazhi ·Xiaofeng Wang, Xiaohong Chen, Zhihong Li, Chuanshang Wang, (unknown), (unknown), (unknown), Miao Zhang, (unknown)	5
20	ORDOVICIAN-SILURIAN BOUNDARY BIOSTRATIGRAPHY OF EASTERN YANGTZE GORGES, CHINA 1984 ·Science China Chemistry ·Xiaofeng Wang, (unknown), (unknown), (unknown), (unknown), Zhihong Li	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact